LGN EBITDA | Legence Corp.

Legence Corp. (LGN) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$6.62M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income $22.37M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $37.20M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income $31.33M; Depreciation and amortization (m).

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$6.62M	(m)	$1.26B	(m)	$24.05M*	$74.38M*	$1.04B	(m)	$147.59M	$11.09M
2026-03-31	Reported	(m)	$22.37M	(m)	$1.04B	(m)	$17.82M	$120.11M	$851.74M	(m)	$116.09M	-$13.38M
2025-09-30	Reported	(m)	$37.20M	(m)	$708.01M	(m)	$10.57M*	$99.58M*	$559.95M	(m)	$85.89M	$4.08M
2025-06-30	Reported	(m)	$31.33M	(m)	$598.89M	(m)	$8.80M*	$33.08M*	$470.22M	(m)	$72.47M	$5.55M
2025-03-31	Reported	(m)	$16.55M	(m)	$505.95M	(m)	$5.36M	$29.46M	$394.25M	(m)	$69.46M	$4.04M
2024-09-30	Reported	(m)	$26.95M	(m)	$560.80M	(m)	(m)	(m)	$442.26M	(m)	$67.20M	$4.56M

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$61.58M	(m)	$2.55B	(m)	$37.94M	$256.87M	$2.01B	(m)	$342.63M	$22.16M
2024-12-31	Reported	(m)	$70.35M	(m)	$2.10B	(m)	$19.01M	$29.27M	$1.67B	(m)	$242.89M	$4.52M
2023-12-31	Reported	(m)	$10.26M	(m)	$1.62B	(m)	$17.07M	$33.92M	$1.30B	(m)	$186.06M	-$7.92M